But if new market entrants aren't able to submit an application and get it through the FDA, then guess what? You have, in this case, Mylan, who is able to market a product, quickly raise the price, bring home an exorbitant amount of profit, with no competition.
Buck discusses the lack of competition in the pharmaceutical market leading to high prices.
Share & report
More from Ken Buck
I have come out strongly and said there is no direct evidence linking President Biden to the activities of Hunter Biden.
The border is unacceptable and nobody on either side can argue that we should continue the status quo.
I am fine with an improved immigration process. We need to fix our legal immigration process, so those folks who are -- who want to come to this country, to improve their economic status, give their kids a better chance at life and they…
Other voices in this conversation
